Archive: 11/03/2015

Unituxin approved for deadly pediatric cancer

(HealthDay)—Unituxin (dinutuximab) has been approved by the U.S. Food and Drug Administration to treat children with high-risk neuroblastoma, a rare cancer that most often affects children aged five and under.

page 8 from 9